Autoimmune pancreatitis
A form of pancreatitis caused by the body's immune system attacking the pancreas
Autoimmune pancreatitis (AIP) is a rare form of chronic pancreatitis characterized by an autoimmune inflammatory process that affects the pancreas. It is part of a spectrum of autoimmune diseases and is often associated with other systemic autoimmune conditions.
Classification[edit | edit source]
Autoimmune pancreatitis is classified into two types:
- Type 1 AIP: Also known as lymphoplasmacytic sclerosing pancreatitis, this type is associated with IgG4-related disease. It is characterized by elevated serum IgG4 levels and the presence of IgG4-positive plasma cells in the pancreas.
- Type 2 AIP: Also known as idiopathic duct-centric pancreatitis, this type is not associated with IgG4-related disease. It is characterized by granulocytic epithelial lesions and is often associated with inflammatory bowel disease, such as ulcerative colitis.
Signs and symptoms[edit | edit source]
Patients with autoimmune pancreatitis may present with a variety of symptoms, including:
- Jaundice due to bile duct obstruction
- Abdominal pain
- Weight loss
- Diabetes mellitus
- Pancreatic insufficiency leading to steatorrhea
Diagnosis[edit | edit source]
The diagnosis of autoimmune pancreatitis is based on a combination of clinical, serological, radiological, and histological findings. Key diagnostic criteria include:
- Elevated serum IgG4 levels (particularly in Type 1 AIP)
- Characteristic imaging findings on CT scan or MRI, such as diffuse or focal pancreatic enlargement and a "sausage-shaped" pancreas
- Histological examination showing lymphoplasmacytic infiltration and fibrosis
- Response to corticosteroid therapy
Treatment[edit | edit source]
The primary treatment for autoimmune pancreatitis is corticosteroid therapy, which typically leads to rapid improvement in symptoms and imaging findings. In some cases, additional immunosuppressive agents such as azathioprine or mycophenolate mofetil may be used to maintain remission.
Prognosis[edit | edit source]
With appropriate treatment, the prognosis for autoimmune pancreatitis is generally good. However, relapses can occur, and long-term follow-up is necessary to monitor for recurrence and manage any associated autoimmune conditions.
Related pages[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD